ACCESSION: MSBNK-SMB_Measured-HSA001P0193001
RECORD_TITLE: Uncharacterized; LC-ESI-QFT; MS2; POSITIVE; Averaged data
DATE: 2025.04.02 (Averaged 2025.02.17, Processed 2025.02.17, Annotated 2025.03.05, Curated 2025.04.02)
AUTHORS: Shin-MassBank project
LICENSE: CC BY-NC-SA
PUBLICATION: Shin-MassBank project in preparation
COMMENT: This is an averaged mass spectra data created by averaging product ion scan data obtained from the following DDA dataset.
COMMENT: REPOSITORY MB-POST
COMMENT: DATASET_ID MPST000004
COMMENT: DATASET_TITLE Annotation of various metabolites in SRM 1950 human serum
COMMENT: DATASET_AUTHORS Masatomo Takahashi, Yoshihiro Izumi, Kyoshu University
COMMENT: MS1_M/Z_AVERAGED_THRES 0.750
COMMENT: MS2_M/Z_AVERAGED_THRES 4.000
COMMENT: DATASET_FILE_NUM 22
COMMENT: NUM_AVERAGED_SPEC 242
COMMENT: RAW_SPEC {'BLK01_2573': {'bp': 732220.0, 'sum': 938474.0}, '11_posi_2554': {'bp': 244347.0, 'sum': 544987.0}, '11_posi_2426': {'bp': 179675.0, 'sum': 424106.0}, '10_posi_2447': {'bp': 199862.0, 'sum': 431667.0}, '14_posi_2406': {'bp': 162241.0, 'sum': 384425.0}, '16_posi_2471': {'bp': 185097.0, 'sum': 446302.0}, '4_posi_2470': {'bp': 231010.0, 'sum': 447263.0}, '16_posi_2551': {'bp': 214533.0, 'sum': 523545.0}, '19_posi_2593': {'bp': 180631.0, 'sum': 429524.0}, '8_posi_2488': {'bp': 171608.0, 'sum': 356612.0}, '7_posi_2553': {'bp': 231048.0, 'sum': 482683.0}, '18_posi_2574': {'bp': 208387.0, 'sum': 473145.0}, '1_posi_2383': {'bp': 201409.0, 'sum': 415707.0}, '10_posi_2510': {'bp': 199536.0, 'sum': 447339.0}, '5_posi_2531': {'bp': 186626.0, 'sum': 394905.0}, '18_posi_2490': {'bp': 175388.0, 'sum': 479773.0}, '15_posi_2469': {'bp': 164716.0, 'sum': 392592.0}, '1_posi_2971': {'bp': 337518.0, 'sum': 578560.0}, '3_posi_2512': {'bp': 238164.0, 'sum': 508023.0}, '4_posi_2385': {'bp': 189021.0, 'sum': 419491.0}, '8_posi_2929': {'bp': 224315.0, 'sum': 413166.0}, '7_posi_2489': {'bp': 223400.0, 'sum': 464239.0}, '9_posi_2574': {'bp': 205670.0, 'sum': 452377.0}, '13_posi_2653': {'bp': 203320.0, 'sum': 500255.0}, '9_posi_2659': {'bp': 201999.0, 'sum': 519058.0}, '5_posi_2466': {'bp': 154308.0, 'sum': 347918.0}, '11_posi_2344': {'bp': 136488.0, 'sum': 375051.0}, '1_posi_2446': {'bp': 256294.0, 'sum': 507533.0}, '5_posi_2405': {'bp': 195868.0, 'sum': 450860.0}, '11_posi_2639': {'bp': 183415.0, 'sum': 470306.0}, '6_posi_2469': {'bp': 168150.0, 'sum': 374637.0}, '1_posi_2844': {'bp': 325201.0, 'sum': 581752.0}, '19_posi_3100': {'bp': 245585.0, 'sum': 554807.0}, '15_posi_2721': {'bp': 202406.0, 'sum': 535499.0}, '13_posi_2511': {'bp': 172892.0, 'sum': 382053.0}, '7_posi_2408': {'bp': 160144.0, 'sum': 366627.0}, '1_posi_2782': {'bp': 323940.0, 'sum': 557868.0}, '13_posi_2995': {'bp': 275953.0, 'sum': 526013.0}, '9_posi_2824': {'bp': 209602.0, 'sum': 452154.0}, '4_posi_2783': {'bp': 209316.0, 'sum': 420083.0}, 'BLK02_2323': {'bp': 203945.0, 'sum': 462426.0}, '11_posi_2806': {'bp': 189827.0, 'sum': 440123.0}, '13_posi_2427': {'bp': 177894.0, 'sum': 411946.0}, '15_posi_3225': {'bp': 265297.0, 'sum': 443219.0}, '18_posi_3264': {'bp': 262854.0, 'sum': 461463.0}, '16_posi_3285': {'bp': 254449.0, 'sum': 440868.0}, '10_posi_2928': {'bp': 252457.0, 'sum': 524765.0}, '10_posi_2572': {'bp': 236430.0, 'sum': 554949.0}, '18_posi_3013': {'bp': 231374.0, 'sum': 559373.0}, '6_posi_2618': {'bp': 230581.0, 'sum': 513086.0}, 'ProcedureBlank_2442': {'bp': 221736.0, 'sum': 443262.0}, '2_posi_2552': {'bp': 212518.0, 'sum': 458688.0}, '18_posi_2656': {'bp': 212073.0, 'sum': 539803.0}, '5_posi_2782': {'bp': 200129.0, 'sum': 434300.0}, '14_posi_2660': {'bp': 195076.0, 'sum': 502192.0}, '15_posi_2554': {'bp': 193949.0, 'sum': 435149.0}, '8_posi_2639': {'bp': 185901.0, 'sum': 435964.0}, '9_posi_2446': {'bp': 180707.0, 'sum': 409741.0}, '12_posi_2427': {'bp': 164014.0, 'sum': 410055.0}, 'ProcedureBlank_3286': {'bp': 378866.0, 'sum': 641495.0}, 'ProcedureBlank_2631': {'bp': 293252.0, 'sum': 583716.0}, '13_posi_2719': {'bp': 249256.0, 'sum': 598906.0}, '11_posi_2489': {'bp': 249118.0, 'sum': 531396.0}, '14_posi_2889': {'bp': 241188.0, 'sum': 513295.0}, '11_posi_2888': {'bp': 229489.0, 'sum': 469163.0}, '9_posi_2510': {'bp': 203705.0, 'sum': 466390.0}, '19_posi_2511': {'bp': 191010.0, 'sum': 508228.0}, '14_posi_2491': {'bp': 175230.0, 'sum': 435167.0}, 'BLK02_2906': {'bp': 408566.0, 'sum': 655864.0}, '3_posi_2912': {'bp': 319948.0, 'sum': 564839.0}, '13_posi_3162': {'bp': 274399.0, 'sum': 468603.0}, '13_posi_3244': {'bp': 270605.0, 'sum': 463855.0}, '13_posi_3078': {'bp': 266302.0, 'sum': 516035.0}, '1_posi_2511': {'bp': 255335.0, 'sum': 516837.0}, '3_posi_2780': {'bp': 240978.0, 'sum': 474522.0}, '13_posi_2848': {'bp': 230045.0, 'sum': 484550.0}, '17_posi_2575': {'bp': 194865.0, 'sum': 453606.0}, '8_posi_2407': {'bp': 153197.0, 'sum': 392716.0}, '1_posi_3243': {'bp': 359561.0, 'sum': 576011.0}, 'ProcedureBlank_2568': {'bp': 340015.0, 'sum': 685421.0}, '1_posi_2909': {'bp': 319426.0, 'sum': 551928.0}, '6_posi_2887': {'bp': 308080.0, 'sum': 572433.0}, 'BLK02_2464': {'bp': 276838.0, 'sum': 558993.0}, '11_posi_2953': {'bp': 270141.0, 'sum': 500466.0}, '17_posi_2993': {'bp': 267358.0, 'sum': 538557.0}, '8_posi_3056': {'bp': 245510.0, 'sum': 454359.0}, '4_posi_2553': {'bp': 238913.0, 'sum': 524560.0}, '7_posi_2701': {'bp': 233843.0, 'sum': 530142.0}, '19_posi_3035': {'bp': 221065.0, 'sum': 536689.0}, '4_posi_2636': {'bp': 217892.0, 'sum': 485554.0}, '8_posi_2555': {'bp': 210830.0, 'sum': 424938.0}, '12_posi_2509': {'bp': 209064.0, 'sum': 473908.0}, '12_posi_2639': {'bp': 203769.0, 'sum': 504885.0}, '17_posi_2491': {'bp': 173965.0, 'sum': 462254.0}, '14_posi_2574': {'bp': 168704.0, 'sum': 420798.0}, 'BLK02_2843': {'bp': 466449.0, 'sum': 821582.0}, 'BLK02_2969': {'bp': 459205.0, 'sum': 754123.0}, 'BLK02_2593': {'bp': 432896.0, 'sum': 818582.0}, 'ProcedureBlank_2823': {'bp': 377471.0, 'sum': 680530.0}, 'ProcedureBlank_2696': {'bp': 371260.0, 'sum': 649631.0}, 'ProcedureBlank_2883': {'bp': 321546.0, 'sum': 567175.0}, 'ProcedureBlank_2507': {'bp': 308710.0, 'sum': 600117.0}, '1_posi_2719': {'bp': 288564.0, 'sum': 602410.0}, '13_posi_2929': {'bp': 287769.0, 'sum': 551651.0}, '10_posi_3200': {'bp': 283322.0, 'sum': 475489.0}, '11_posi_3265': {'bp': 271748.0, 'sum': 464914.0}, '7_posi_3140': {'bp': 258195.0, 'sum': 466350.0}, '15_posi_2865': {'bp': 243538.0, 'sum': 571819.0}, '16_posi_3097': {'bp': 241983.0, 'sum': 468852.0}, '9_posi_2889': {'bp': 226653.0, 'sum': 483133.0}, 'ProcedureBlank_2378': {'bp': 221378.0, 'sum': 473706.0}, '10_posi_2638': {'bp': 219507.0, 'sum': 536968.0}, '6_posi_2552': {'bp': 215591.0, 'sum': 434286.0}, '3_posi_2427': {'bp': 213932.0, 'sum': 491733.0}, '6_posi_2403': {'bp': 174373.0, 'sum': 424899.0}, 'ProcedureBlank_3223': {'bp': 414815.0, 'sum': 633744.0}, '1_posi_3117': {'bp': 381165.0, 'sum': 619653.0}, '7_posi_2931': {'bp': 299521.0, 'sum': 533450.0}, '1_posi_2654': {'bp': 278455.0, 'sum': 528624.0}, '4_posi_2993': {'bp': 271434.0, 'sum': 504489.0}, '14_posi_3099': {'bp': 262652.0, 'sum': 448477.0}, 'BLK02_2402': {'bp': 258718.0, 'sum': 523103.0}, '7_posi_2782': {'bp': 244584.0, 'sum': 488675.0}, '12_posi_3307': {'bp': 243724.0, 'sum': 440412.0}, '6_posi_2953': {'bp': 240274.0, 'sum': 474758.0}, '18_posi_2951': {'bp': 238028.0, 'sum': 543524.0}, '19_posi_3269': {'bp': 234479.0, 'sum': 440218.0}, '6_posi_2806': {'bp': 215662.0, 'sum': 433098.0}, 'BLK02_3282': {'bp': 526401.0, 'sum': 782524.0}, 'BLK02_3219': {'bp': 488247.0, 'sum': 734984.0}, '1_posi_3178': {'bp': 373829.0, 'sum': 597763.0}, 'ProcedureBlank_2953': {'bp': 331199.0, 'sum': 566282.0}, '3_posi_2994': {'bp': 319597.0, 'sum': 597699.0}, '12_posi_3101': {'bp': 313471.0, 'sum': 545305.0}, '2_posi_3057': {'bp': 304808.0, 'sum': 518568.0}, '5_posi_3057': {'bp': 297584.0, 'sum': 520959.0}, '6_posi_3268': {'bp': 294470.0, 'sum': 486195.0}, '15_posi_3161': {'bp': 289892.0, 'sum': 496667.0}, '12_posi_2907': {'bp': 282435.0, 'sum': 514474.0}, '4_posi_2911': {'bp': 277191.0, 'sum': 536793.0}, '14_posi_3182': {'bp': 268196.0, 'sum': 489257.0}, '4_posi_2846': {'bp': 260835.0, 'sum': 508901.0}, '11_posi_3036': {'bp': 257354.0, 'sum': 490230.0}, '17_posi_3308': {'bp': 255680.0, 'sum': 448460.0}, '1_posi_2591': {'bp': 250067.0, 'sum': 512713.0}, '12_posi_2972': {'bp': 249516.0, 'sum': 486247.0}, '9_posi_3202': {'bp': 244535.0, 'sum': 387622.0}, '17_posi_3056': {'bp': 242948.0, 'sum': 483021.0}, '10_posi_3264': {'bp': 225953.0, 'sum': 394291.0}, '5_posi_2591': {'bp': 216613.0, 'sum': 502167.0}, '13_posi_2591': {'bp': 188574.0, 'sum': 439179.0}, '2_posi_2344': {'bp': 144363.0, 'sum': 400543.0}, 'BLK02_2780': {'bp': 481219.0, 'sum': 889588.0}, 'ProcedureBlank_2758': {'bp': 357530.0, 'sum': 662165.0}, '2_posi_2993': {'bp': 349427.0, 'sum': 603542.0}, '3_posi_3202': {'bp': 338896.0, 'sum': 515830.0}, '3_posi_3076': {'bp': 319988.0, 'sum': 554841.0}, '10_posi_2992': {'bp': 317575.0, 'sum': 572421.0}, '4_posi_3309': {'bp': 276364.0, 'sum': 497900.0}, '8_posi_3286': {'bp': 273446.0, 'sum': 486782.0}, '17_posi_3117': {'bp': 267627.0, 'sum': 488187.0}, '14_posi_3307': {'bp': 261246.0, 'sum': 460052.0}, '10_posi_3055': {'bp': 260946.0, 'sum': 471022.0}, '15_posi_2930': {'bp': 257757.0, 'sum': 537781.0}, '16_posi_2932': {'bp': 257071.0, 'sum': 568731.0}, '15_posi_2994': {'bp': 254530.0, 'sum': 491019.0}, '15_posi_3305': {'bp': 251551.0, 'sum': 424797.0}, '18_posi_3076': {'bp': 249949.0, 'sum': 543004.0}, '7_posi_2635': {'bp': 213733.0, 'sum': 519121.0}, '2_posi_2489': {'bp': 210040.0, 'sum': 411002.0}, 'ProcedureBlank_3159': {'bp': 399690.0, 'sum': 618362.0}, 'BLK02_2655': {'bp': 352949.0, 'sum': 674712.0}, 'BLK02_2717': {'bp': 351950.0, 'sum': 688973.0}, 'BLK02_2529': {'bp': 310398.0, 'sum': 645382.0}, '3_posi_3265': {'bp': 306763.0, 'sum': 477710.0}, '12_posi_3035': {'bp': 298295.0, 'sum': 515115.0}, '2_posi_2828': {'bp': 289031.0, 'sum': 549103.0}, '6_posi_3099': {'bp': 288288.0, 'sum': 498304.0}, '14_posi_2971': {'bp': 287714.0, 'sum': 566776.0}, '12_posi_3182': {'bp': 284319.0, 'sum': 477779.0}, '3_posi_2846': {'bp': 280214.0, 'sum': 529151.0}, '16_posi_3016': {'bp': 262599.0, 'sum': 553081.0}, '3_posi_2592': {'bp': 260597.0, 'sum': 568996.0}, '16_posi_3161': {'bp': 255661.0, 'sum': 458069.0}, '17_posi_3245': {'bp': 252721.0, 'sum': 446641.0}, '11_posi_3119': {'bp': 243966.0, 'sum': 453390.0}, '2_posi_2676': {'bp': 242358.0, 'sum': 558502.0}, '19_posi_3185': {'bp': 239050.0, 'sum': 464635.0}, '3_posi_2656': {'bp': 237106.0, 'sum': 555177.0}, '12_posi_2845': {'bp': 218635.0, 'sum': 467377.0}, '12_posi_2573': {'bp': 196952.0, 'sum': 436491.0}, 'BLK02_3156': {'bp': 476699.0, 'sum': 785360.0}, '2_posi_3138': {'bp': 379391.0, 'sum': 601257.0}, '2_posi_3204': {'bp': 357758.0, 'sum': 570673.0}, '2_posi_2910': {'bp': 323237.0, 'sum': 584784.0}, '4_posi_3059': {'bp': 311780.0, 'sum': 517237.0}, '9_posi_2971': {'bp': 267265.0, 'sum': 485349.0}, '7_posi_2847': {'bp': 264980.0, 'sum': 518837.0}, '8_posi_2847': {'bp': 255098.0, 'sum': 508526.0}, '18_posi_3202': {'bp': 245399.0, 'sum': 479955.0}, '13_posi_3308': {'bp': 244816.0, 'sum': 428860.0}, '15_posi_3079': {'bp': 230931.0, 'sum': 478187.0}, '14_posi_2825': {'bp': 219611.0, 'sum': 497970.0}, '2_posi_2426': {'bp': 204213.0, 'sum': 417386.0}, 'BLK02_3093': {'bp': 510190.0, 'sum': 805240.0}, '2_posi_3287': {'bp': 311990.0, 'sum': 511695.0}, '3_posi_3139': {'bp': 310471.0, 'sum': 521740.0}, '5_posi_2927': {'bp': 286526.0, 'sum': 533111.0}, '9_posi_3057': {'bp': 285691.0, 'sum': 492816.0}, '4_posi_3223': {'bp': 272894.0, 'sum': 452239.0}, '2_posi_2614': {'bp': 272033.0, 'sum': 554531.0}, '5_posi_2991': {'bp': 261426.0, 'sum': 485726.0}, '5_posi_2847': {'bp': 260355.0, 'sum': 515663.0}, '9_posi_3139': {'bp': 257270.0, 'sum': 437889.0}, '14_posi_3033': {'bp': 253072.0, 'sum': 489059.0}, '8_posi_3121': {'bp': 252582.0, 'sum': 426734.0}, '10_posi_2848': {'bp': 224824.0, 'sum': 486311.0}, '19_posi_2658': {'bp': 192651.0, 'sum': 453654.0}, 'BLK02_3032': {'bp': 452411.0, 'sum': 700972.0}, 'ProcedureBlank_3096': {'bp': 411659.0, 'sum': 682920.0}, '1_posi_3305': {'bp': 350122.0, 'sum': 549681.0}, '5_posi_3263': {'bp': 298445.0, 'sum': 481628.0}, '14_posi_3245': {'bp': 278303.0, 'sum': 487540.0}, '18_posi_3140': {'bp': 273460.0, 'sum': 562845.0}, '7_posi_3076': {'bp': 264775.0, 'sum': 487895.0}, '8_posi_2993': {'bp': 260671.0, 'sum': 456407.0}, '12_posi_3244': {'bp': 250330.0, 'sum': 451868.0}, '17_posi_3182': {'bp': 245617.0, 'sum': 466118.0}, '7_posi_3266': {'bp': 285898.0, 'sum': 456425.0}, '17_posi_2930': {'bp': 237573.0, 'sum': 565147.0}, '16_posi_2847': {'bp': 218228.0, 'sum': 516638.0}, '5_posi_3136': {'bp': 301185.0, 'sum': 522037.0}, '10_posi_3120': {'bp': 277775.0, 'sum': 501312.0}, '16_posi_3222': {'bp': 265738.0, 'sum': 455069.0}, '2_posi_2742': {'bp': 224053.0, 'sum': 480473.0}, '9_posi_3264': {'bp': 321680.0, 'sum': 541404.0}, '6_posi_3034': {'bp': 272649.0, 'sum': 493719.0}, '7_posi_3202': {'bp': 262642.0, 'sum': 457400.0}, '7_posi_3012': {'bp': 245260.0, 'sum': 473111.0}, 'ProcedureBlank_3033': {'bp': 373094.0, 'sum': 581824.0}, '11_posi_3183': {'bp': 259607.0, 'sum': 464065.0}, '5_posi_3201': {'bp': 320258.0, 'sum': 539361.0}}
COMMENT: RETENTION_TIME_STDEV 0.572
COMMENT: PRECURSOR_M/Z_RAW 193.144440
COMMENT: PRECURSOR_M/Z_STDEV 0.000088
COMMENT: PRECURSOR_IN_MS1 mz 193.144749; int 35.898; delta(ppm) 0.926703
COMMENT: PROPOSED_CHARGE_STATE +1; mz 194.148052; int 3.635; cor 0.609
COMMENT: PROPOSED_ISOTOPE_STATE ND
COMMENT: PROPOSED_ION_FORM M+ACN+H; M+NH4; mz 169.144749; int 646.965; cor 0.655
COMMENT: PROPOSED_MAX_NUM_S 0
COMMENT: PROPOSED_MF SevenGoldenRules 0.125; C10H16N4; [M+H]+; delta(ppm) -0.124911
COMMENT: PROPOSED_MF SevenGoldenRules 0.139; C8H13N3; [M+ACN+H]+; delta(ppm) -0.138971
COMMENT: PROPOSED_MF MS-FINDER 3.883; C8H13N3; [M+ACN+H]+; delta(ppm) 84343.934740
COMMENT: PROPOSED_MF MS-FINDER 3.691; C10H16N4; [M+H]+; delta(ppm) -0.124114
COMMENT: PROPOSED_MF SIRIUS5_Sirius 6.689; C8H13N3; [M+C2H3N+H]+; delta(ppm) -0.124114
COMMENT: PROPOSED_MF SIRIUS5_Sirius 6.689; C10H16N4; [M+H]+; delta(ppm) -0.124114
COMMENT: PROPOSED_MF SIRIUS5_Sirius 4.822; C9H20O4; [M+H]+; delta(ppm) 6.800346
COMMENT: PROPOSED_MF SIRIUS5_Zodiac 1.000; C8H13N3; [M+C2H3N+H]+; delta(ppm) -0.124114
COMMENT: PROPOSED_MF SIRIUS5_Zodiac 1.000; C10H16N4; [M+H]+; delta(ppm) -0.124114
COMMENT: PROPOSED_MF SIRIUS6_Sirius 13.165; C8H13N3; [M+C2H3N+H]+; delta(ppm) -0.124114
COMMENT: PROPOSED_MF SIRIUS6_Sirius 13.165; C10H16N4; [M+H]+; delta(ppm) -0.124114
COMMENT: PROPOSED_MF SIRIUS6_Sirius 6.117; C5H14FN3O; [M+C2H3N+H]+; delta(ppm) -6.040127
COMMENT: PROPOSED_MF SIRIUS6_Sirius 6.117; C7H17FN4O; [M+H]+; delta(ppm) -6.040127
COMMENT: PROPOSED_MF SIRIUS6_Sirius 3.829; C9H20O4; [M+H]+; delta(ppm) 6.800346
COMMENT: PROPOSED_MF SIRIUS6_Sirius 3.468; C9H21ClN2; [M+H]+; delta(ppm) -110532.947659
COMMENT: PROPOSED_MF SIRIUS6_Sirius -1.106; C10H15O; [M+C2H3N+H]+; delta(ppm) -7.075656
COMMENT: PROPOSED_MF SIRIUS6_Sirius -1.106; C12H18NO; [M+H]+; delta(ppm) -7.075656
COMMENT: PROPOSED_MF SIRIUS6_Sirius -1.897; C8H21N2OP; [M+H]+; delta(ppm) -8.676001
COMMENT: PROPOSED_MF SIRIUS6_Sirius -5.922; C4H16N4P; [M+C2H3N+H]+; delta(ppm) -1.724481
COMMENT: PROPOSED_MF SIRIUS6_Sirius -5.922; C6H19N5P; [M+H]+; delta(ppm) -1.724481
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 1.000; C8H13N3; [M+C2H3N+H]+; delta(ppm) -0.124114
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 1.000; C10H16N4; [M+H]+; delta(ppm) -0.124114
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.278; AVTLBBWTUPQRAY-UHFFFAOYNA-N; [M+H]+; 2,2'-azobis[2-methylbutyronitrile]
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.252; OIFIPRUEJLZKTO-UHFFFAOYSA-N; [M+H]+; 2-[5-(cyanomethyl)-1,5-diazocan-1-yl]acetonitrile
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.089; NTAYHZGUFNPVLG-UHFFFAOYSA-N; [M+H]+; 1,5,6,7-tetrahydrospiro[imidazo[4,5-c]pyridine-4,4'-piperidine]
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.950; JAOSYYPULNBONK-UHFFFAOYSA-N; [M+ACN+H]+; N'-(pyridin-2-ylmethyl)ethane-1,2-diamine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 1.000; NTAYHZGUFNPVLG-UHFFFAOYSA-N; [M+H]+; 1,5,6,7-tetrahydrospiro[imidazo[4,5-c]pyridine-4,4'-piperidine]
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 1.000; JAOSYYPULNBONK-UHFFFAOYSA-N; [M+ACN+H]+; N'-(pyridin-2-ylmethyl)ethane-1,2-diamine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.992; OIFIPRUEJLZKTO-UHFFFAOYSA-N; [M+H]+; 2-[5-(cyanomethyl)-1,5-diazocan-1-yl]acetonitrile
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.761; AVTLBBWTUPQRAY-UHFFFAOYNA-N; [M+H]+; 2,2'-azobis[2-methylbutyronitrile]
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 3.680; JAOSYYPULNBONK-UHFFFAOYSA-N; [M+ACN+H]+; N'-(pyridin-2-ylmethyl)ethane-1,2-diamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 3.357; WGNPNAOPVBYTKD-UHFFFAOYSA-N; [M+ACN+H]+; 4-pyrazol-1-ylpiperidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.923; AVTLBBWTUPQRAY-UHFFFAOYSA-N; [M+H]+; 2-(2-cyanobutan-2-yldiazenyl)-2-methylbutanenitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.855; KTEPQLOOQDLKHF-BQBZGAKWSA-N; [M+ACN+H]+; 5-[(3R,4R)-4-methylpyrrolidin-3-yl]-1H-imidazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.825; TVARKMCEMIFLIP-UHFFFAOYSA-N; [M+ACN+H]+; 4-N-(2-aminoethyl)benzene-1,4-diamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.778; QXQYJEMSNUMUPO-UHFFFAOYSA-N; [M+H]+; 3-[4-(2-cyanoethyl)piperazin-1-yl]propanenitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.319; NNDJCSXUAYKMAA-UHFFFAOYSA-N; [M+ACN+H]+; 4-(1H-imidazol-5-yl)piperidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.277; DZMZZFAVAYXTJD-UHFFFAOYSA-N; [M+ACN+H]+; 3-(1H-pyrazol-5-yl)piperidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.250; FCKYIGWJVZIPLK-UHFFFAOYSA-N; [M+ACN+H]+; 4-(1H-pyrazol-5-yl)piperidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.240; YJIDKQVYACIBPR-UHFFFAOYSA-N; [M+ACN+H]+; 5-(aminomethyl)-N,N-dimethylpyridin-2-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.223; WVBVSEUWCRPAPY-UHFFFAOYSA-N; [M+ACN+H]+; 4-imidazol-1-ylpiperidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.205; GVFMWHPJTZVYIF-UHFFFAOYSA-N; [M+ACN+H]+; 6-tert-butylpyrimidin-4-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.131; YJNKIVCXVAKYRD-UHFFFAOYSA-N; [M+ACN+H]+; 4-(1H-imidazol-2-yl)piperidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.063; PJYRTBHVJDCKCQ-UHFFFAOYSA-N; [M+ACN+H]+; 5-[(dimethylamino)methyl]pyridin-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.059; AEPYIICGYIUTCV-UHFFFAOYSA-N; [M+ACN+H]+; 4-N,4-N-dimethylbenzene-1,2,4-triamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.034; SDVRXHFNSQTUGR-UHFFFAOYSA-N; [M+ACN+H]+; 5-[(dimethylamino)methyl]pyridin-2-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.014; VYXZVYMNCWBSBV-UHFFFAOYSA-N; [M+ACN+H]+; 4-N,4-N,6-trimethylpyridine-2,4-diamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.007; JXAOKSJVAAOSEM-UHFFFAOYSA-N; [M+ACN+H]+; 4-[(dimethylamino)methyl]pyridin-2-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.986; BSEXLDBVQJQABI-UHFFFAOYSA-N; [M+ACN+H]+; 5-(aminomethyl)-4,6-dimethylpyridin-2-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.980; JNIGJXJBRHGJBY-UHFFFAOYSA-N; [M+ACN+H]+; 1-(azetidin-3-yl)-3,5-dimethylpyrazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.968; APYVQYYSQIBHCE-UHFFFAOYSA-N; [M+ACN+H]+; 5-cyclopropyl-1-ethylpyrazol-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.959; GHXWDWIQFQJWEQ-UHFFFAOYSA-N; [M+ACN+H]+; N-methyl-N'-pyridin-2-ylethane-1,2-diamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.953; LLIDKFDJRJTVSN-UHFFFAOYSA-N; [M+ACN+H]+; 1-methyl-4-pyrrolidin-3-ylpyrazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.947; FVBLFJODKIHJMW-UHFFFAOYSA-N; [M+ACN+H]+; 4-(aminomethyl)-N,N-dimethylpyridin-2-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.947; WSDSLOJOKKCEHE-UHFFFAOYSA-N; [M+ACN+H]+; 6-(aminomethyl)-N,N-dimethylpyridin-2-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.942; ZEZGYBRKRWWUNW-UHFFFAOYSA-N; [M+ACN+H]+; 2-N,2-N,6-trimethylpyridine-2,5-diamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.937; OVEZWSXZQCHUEP-UHFFFAOYSA-N; [M+ACN+H]+; 3-pyrazol-1-ylpiperidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.931; YENOREWNIMNEIM-UHFFFAOYSA-N; [M+ACN+H]+; 4-(aminomethyl)-N-ethylpyridin-2-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.931; LRMLNAXJNYRHHZ-UHFFFAOYSA-N; [M+ACN+H]+; 3-(aminomethyl)-N,N-dimethylpyridin-2-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.928; VLEDIUXXQKUSRF-UHFFFAOYSA-N; [M+ACN+H]+; 1-methyl-3-pyrrolidin-2-ylpyrazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.927; CBBNMRHBOTWANO-UHFFFAOYSA-N; [M+ACN+H]+; 2-(aminomethyl)-N,N-dimethylpyridin-4-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.925; HJMDKIXQKXDUMY-UHFFFAOYSA-N; [M+ACN+H]+; 1-methyl-5-pyrrolidin-2-ylpyrazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.923; GJQDDUPLCDQOHZ-UHFFFAOYSA-N; [M+ACN+H]+; 2-(1H-imidazol-2-yl)piperidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.918; OKLVXPSKPCTBGL-UHFFFAOYSA-N; [M+ACN+H]+; 4-tert-butylpyrimidin-2-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.915; YBTUXCHNVVZSSQ-UHFFFAOYSA-N; [M+ACN+H]+; 2,5-dimethyl-3,4,6,7-tetrahydroimidazo[4,5-c]pyridine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.914; VRQSNISBSWLYIN-UHFFFAOYSA-N; [M+ACN+H]+; 1-methyl-4-pyrrolidin-2-ylpyrazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.914; HVIXJTLUHJSOIV-UHFFFAOYSA-N; [M+ACN+H]+; 1-cyclopropylpiperazine-2-carbonitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.913; XQPHBZLBMGDDMS-UHFFFAOYSA-N; [M+ACN+H]+; 2-(aminomethyl)-N,N-dimethylpyridin-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.906; TZMWSWHAIQULJZ-UHFFFAOYSA-N; [M+ACN+H]+; 2-N,2-N,6-trimethylpyridine-2,3-diamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.903; WLBFPIISFPQQSE-UHFFFAOYSA-N; [M+ACN+H]+; 3-(3-but-3-ynyldiazirin-3-yl)propan-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.899; YNPUVQQTJNVFFL-UHFFFAOYSA-N; [M+ACN+H]+; 2-[(dimethylamino)methyl]pyridin-4-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.899; FDYNVUGZXKGSHY-UHFFFAOYSA-N; [M+ACN+H]+; 2-N,2-N,3-N-trimethylpyridine-2,3-diamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.890; VBCUUEAMWQNBNC-UHFFFAOYSA-N; [M+ACN+H]+; 6-(aminomethyl)-N,N-dimethylpyridin-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.886; PXQUZLDSPUWIHH-UHFFFAOYSA-N; [M+ACN+H]+; 4-(1H-pyrazol-4-yl)piperidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.882; UYOZDXASYOYYCF-UHFFFAOYSA-N; [M+ACN+H]+; 3-imidazol-1-ylpiperidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.880; NXDPGCYRUPUNMK-UHFFFAOYSA-N; [M+ACN+H]+; 4-methyl-1-pyrrolidin-3-ylpyrazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.877; CFZKRYFTIHMWBI-UHFFFAOYSA-N; [M+ACN+H]+; 3-(1H-imidazol-2-yl)piperidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.873; VLNMFRPPGPXJHP-MRVPVSSYSA-N; [M+ACN+H]+; 1-[[(2R)-pyrrolidin-2-yl]methyl]imidazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.872; JLCZNKONOKKWEP-UHFFFAOYSA-N; [M+ACN+H]+; 2-(4,6-dimethylpyrimidin-2-yl)ethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.870; WGKTZHNTSOLEDU-UHFFFAOYSA-N; [M+ACN+H]+; 1-methyl-2-pyrrolidin-3-ylimidazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.869; MTEOCSKEEPABCY-UHFFFAOYSA-N; [M+ACN+H]+; 1-(1-cyclopropylimidazol-4-yl)-N-methylmethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.869; LTWYZYKSQWOKKG-UHFFFAOYSA-N; [M+ACN+H]+; 2-(4,5-dimethylpyrimidin-2-yl)ethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.869; JOCSQNKLFNVQPZ-UHFFFAOYSA-N; [M+ACN+H]+; 1-(1-cyclopropylimidazol-2-yl)-N-methylmethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.868; LZQLJAMVAKAJPK-UHFFFAOYSA-N; [M+ACN+H]+; 3-(1H-pyrazol-4-yl)piperidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.866; NROSSDZFPHQESU-UHFFFAOYSA-N; [M+ACN+H]+; 1-(pyrrolidin-2-ylmethyl)pyrazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.862; CKVMGZORIHRUAV-UHFFFAOYSA-N; [M+ACN+H]+; 1-methyl-3-pyrrolidin-3-ylpyrazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.861; BXGQSTJNMGELAB-UHFFFAOYSA-N; [M+ACN+H]+; 1-(3-cyclopropylimidazol-4-yl)-N-methylmethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.861; HNBHVZUDKSBQAR-UHFFFAOYSA-N; [M+ACN+H]+; 1,3-dimethyl-4,5,6,7-tetrahydropyrazolo[3,4-c]pyridine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.859; JNOYHGAZDBVHEM-UHFFFAOYSA-N; [M+ACN+H]+; 2-(1H-pyrazol-5-yl)piperidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.859; JKAHTWBETQEAAS-UHFFFAOYSA-N; [M+ACN+H]+; 1-methyl-2-pyrrolidin-2-ylimidazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.854; QNOKDKCXNOEKGL-UHFFFAOYSA-N; [M+ACN+H]+; 2-(1H-pyrazol-4-yl)piperidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.854; PZNBWWUBSBNMEC-UHFFFAOYSA-N; [M+ACN+H]+; 1-methyl-5-pyrrolidin-3-ylpyrazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.852; MCVCUNCKSFPYHB-UHFFFAOYSA-N; [M+ACN+H]+; 1,2-dimethyl-4,5,6,7-tetrahydroimidazo[4,5-c]pyridine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.848; RONCKQCCYTWWAI-UHFFFAOYSA-N; [M+ACN+H]+; 2,3-dimethyl-5,6,7,8-tetrahydroimidazo[1,2-a]pyrazine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.848; PJGDNWHBPXCOKM-UHFFFAOYSA-N; [M+ACN+H]+; 1,3-dimethyl-5,6,7,8-tetrahydroimidazo[1,5-a]pyrazine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.848; QDECMLXPLVRYBO-UHFFFAOYSA-N; [M+ACN+H]+; 1-methyl-4,5,6,7-tetrahydroindazol-4-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.847; ZOSKVIRKDRGEHE-UHFFFAOYSA-N; [M+ACN+H]+; 2,3-dimethyl-4,5,6,7-tetrahydroimidazo[4,5-c]pyridine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.843; KWEVSQUHBXYCKQ-UHFFFAOYSA-N; [M+ACN+H]+; 1-methyl-5,6,7,8-tetrahydro-4H-pyrazolo[4,3-c]azepine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.843; QLQLPALELJCBOS-UHFFFAOYSA-N; [M+ACN+H]+; 1-methyl-5,6,7,8-tetrahydro-4H-pyrazolo[3,4-c]azepine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.842; FRZORHXWYZCJLG-UHFFFAOYSA-N; [M+ACN+H]+; 2-methyl-5,6,7,8-tetrahydroimidazo[1,2-a]pyridin-6-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.840; JXRNWUSNFVDOSL-UHFFFAOYSA-N; [M+ACN+H]+; 3-methyl-5,6,7,8-tetrahydroimidazo[1,5-a]pyridin-6-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.834; SUDZFHQRNUKXPP-SFYZADRCSA-N; [M+ACN+H]+; (1R,2S)-2-imidazol-1-ylcyclopentan-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.834; NKDOKIULLAFEID-UHFFFAOYSA-N; [M+ACN+H]+; 2-methyl-4,5,6,7-tetrahydroindazol-4-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.833; VIBCWGIBCPTWAD-UHFFFAOYSA-N; [M+ACN+H]+; 3-(pyrazol-1-ylmethyl)cyclobutan-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.832; XPDJVFIJEUVYRF-UHFFFAOYSA-N; [M+ACN+H]+; 2-methyl-4,5,6,7-tetrahydroindazol-5-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.832; JRMWEBHEMFJASH-UHFFFAOYSA-N; [M+ACN+H]+; 3-(imidazol-1-ylmethyl)cyclobutan-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.832; KISKRMOAJAELRC-UHFFFAOYSA-N; [M+ACN+H]+; 6-methyl-4,5,6,7-tetrahydro-1H-indazol-5-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.823; PWVFXOOSNKHFSX-UHFFFAOYSA-N; [M+ACN+H]+; 3-methyl-4,5,6,7-tetrahydro-2H-indazol-5-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.821; OOOAYVNFVFIESQ-UHFFFAOYSA-N; [M+ACN+H]+; 3-methyl-4,5,6,7-tetrahydro-2H-indazol-6-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.815; JGCNHPQMPGHGHT-UHFFFAOYSA-N; [M+ACN+H]+; 2-methyl-4,5,6,7-tetrahydro-3H-benzimidazol-5-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.814; TXOZZTPJCYYMEI-UHFFFAOYSA-N; [M+ACN+H]+; N-[(1-methylpyrazol-4-yl)methyl]cyclopropanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.813; QFOGPABVGAOTCZ-UHFFFAOYSA-N; [M+ACN+H]+; 3-methyl-4,5,6,7-tetrahydrobenzimidazol-5-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.812; HFWXKJZJXPYDAE-UHFFFAOYSA-N; [M+ACN+H]+; 3,5-dimethyl-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrimidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.803; ISHKSHBTYCDAOS-UHFFFAOYSA-N; [M+ACN+H]+; N-methyl-4,5,6,7-tetrahydro-1H-indazol-4-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.803; NLSADDNBPRLSIA-UHFFFAOYSA-N; [M+ACN+H]+; N-methyl-4,5,6,7-tetrahydro-1H-indazol-6-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.792; UJGPGNOWRZXMEW-UHFFFAOYSA-N; [M+ACN+H]+; 5,6,7,8-tetrahydroimidazo[1,2-a]pyridin-7-ylmethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.791; TUAZXHYKCYWEHD-UHFFFAOYSA-N; [M+ACN+H]+; (3-pyrazol-1-ylcyclobutyl)methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.790; KWOSURSYQZBUNY-POYBYMJQSA-N; [M+ACN+H]+; [(1R,2R)-2-(1-methylpyrazol-4-yl)cyclopropyl]methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.789; KTWWCKRURHCDNP-UHFFFAOYSA-N; [M+ACN+H]+; 4,5,6,7-tetrahydro-1H-indazol-6-ylmethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.787; OTTLEYYQAFGTFZ-UHFFFAOYSA-N; [M+ACN+H]+; 5,6,7,8-tetrahydroimidazo[1,2-a]pyridin-5-ylmethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.777; AUVZEJYYMHQPER-UHFFFAOYSA-N; [M+ACN+H]+; 1,5-diazabicyclo[3.2.2]nonane-6-carbonitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.774; IVWNDDHEYWZOHD-UHFFFAOYSA-N; [M+ACN+H]+; 5,6,7,8-tetrahydroimidazo[1,2-a]pyridin-6-ylmethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.773; KAHPGTURDYHTNN-UHFFFAOYSA-N; [M+ACN+H]+; (3-imidazol-1-ylcyclobutyl)methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.769; HUQMVCUMAXSLJG-UHFFFAOYSA-N; [M+ACN+H]+; 5,6,7,8-tetrahydroimidazo[1,2-a]pyridin-8-ylmethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.756; AFGOKLFLQUOZEQ-UHFFFAOYSA-N; [M+ACN+H]+; 2-cyclopentylpyrazol-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.753; WUVGIYMNOOSWPH-UHFFFAOYSA-N; [M+ACN+H]+; N-[(3-methylimidazol-4-yl)methyl]cyclopropanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.748; YHMJZEHNPAQYLH-UHFFFAOYSA-N; [M+ACN+H]+; 3-cyclobutyl-1-methylpyrazol-4-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.708; XSBSEGAHTXBRNY-UHFFFAOYSA-N; [M+ACN+H]+; [1-(1-methylpyrazol-4-yl)cyclopropyl]methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.706; PXEDPQCHOFQXCW-UHFFFAOYSA-N; [M+ACN+H]+; 5-cyclopentyl-1H-pyrazol-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.692; HUOJCVIQWIMKBU-UHFFFAOYSA-N; [M+ACN+H]+; (5-cyclopropyl-2-methylpyrazol-3-yl)methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.683; XHKAMZIANVTROM-UHFFFAOYSA-N; [M+ACN+H]+; (1-methyl-5,6-dihydro-4H-cyclopenta[c]pyrazol-3-yl)methanamine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -75.843; QLTXFTSBONWMPM; [M+H]+; 4,6-dimethyl-2-piperazinylpyrimidine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -84.433; QXQYJEMSNUMUPO; [M+H]+; Bis(cyanoethyl)piperazine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -99.893; NZTCEWZBMOTKCJ; [M+H]+; 6-(4-methylpiperazino)-3-pyridinamine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -103.345; CKEIQUPFORBNCK; [M+C2H3N+H]+; Di(3-cianopropil)ammina
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -107.859; IFHQJBQZOLOOHW; [M+H]+; 2-(4-methylpiperazino)-3-pyridinamine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -114.233; WGNPNAOPVBYTKD; [M+C2H3N+H]+; 4-pyrazol-1-ylpiperidine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -115.694; QDMPMBFLXOWHRY; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -117.042; FCKYIGWJVZIPLK; [M+C2H3N+H]+; 4-(1H-Pyrazol-3-yl)piperidine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -117.495; PJGDNWHBPXCOKM; [M+C2H3N+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -119.787; IPVGRNQKIDXDMG; [M+H]+; Pyrazine, [2-(1-piperazinyl)ethyl]-
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -122.854; UAJACUSQLFALEQ; [M+H]+; 1-(3-Amino-4-pyridyl)-4-methylpiperazine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -123.402; WUWAAVDRLMQLJM; [M+C2H3N+H]+; 5H,6H,7H,8H-imidazo[1,2-a]pyridin-2-ylmethanamine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -123.975; OIFIPRUEJLZKTO; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -127.044; CESKEMSAVOEDCK; [M+C2H3N+H]+; (5-cyclopropyl-1-methylpyrazol-3-yl)methylamine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -131.320; PXQUZLDSPUWIHH; [M+C2H3N+H]+; 4-(1H-pyrazol-4-yl)piperidine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -131.448; GVFMWHPJTZVYIF; [M+C2H3N+H]+; 6-tert-Butyl-4-yrimidinamine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -132.943; XCZJUCJIQIXSBZ; [M+C2H3N+H]+; 3,3''-Iminodibutyronitrile
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -133.180; DYLBXGBJQZSXOY; [M+C2H3N+H]+; Ambpe2042070
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -138.758; DZMZZFAVAYXTJD; [M+C2H3N+H]+; 3-(1H-pyrazol-5-yl)piperidine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -145.986; QDECMLXPLVRYBO; [M+C2H3N+H]+; 1-methyl-4,5,6,7-tetrahydro-1H-indazol-4-amine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -148.313; SVJCAJSBZCGOBS; [M+C2H3N+H]+; N,N,4,6-tetramethylpyrimidin-2-amine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -152.576; OKLVXPSKPCTBGL; [M+C2H3N+H]+; tertbutylpyrimidinamine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -159.455; WVBVSEUWCRPAPY; [M+C2H3N+H]+; 4-Imidazol-1-yl-piperidine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -161.442; BGCZGXQDXVUOKK; [M+C2H3N+H]+; N-(4-Pyridylmethyl)ethylenediamine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -162.281; LZQLJAMVAKAJPK; [M+C2H3N+H]+; 3-(1H-pyrazol-4-yl)piperidine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -165.539; YJIDKQVYACIBPR; [M+C2H3N+H]+; 3-Pyridinemethanamine, 6-(dimethylamino)-
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -166.056; VYXZVYMNCWBSBV; [M+C2H3N+H]+; 4-N,4-N,6-trimethylpyridine-2,4-diamine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -166.889; XQPHBZLBMGDDMS; [M+C2H3N+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -170.810; GURGEEKNRMGVDY; [M+C2H3N+H]+; 2-N,2-N,6-trimethylpyridine-2,4-diamine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -171.451; FVBLFJODKIHJMW; [M+C2H3N+H]+; 4-(aminomethyl)-N,N-dimethylpyridin-2-amine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -183.692; GJQDDUPLCDQOHZ; [M+C2H3N+H]+; 2-(1H-imidazol-2-yl)piperidine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -195.116; PXEDPQCHOFQXCW; [M+C2H3N+H]+; 3-Cyclopentyl-1H-pyrazol-5-amine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -200.517; KTEPQLOOQDLKHF; [M+C2H3N+H]+; 5-(4-methylpyrrolidin-3-yl)-1H-imidazole
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -203.219; KFGHIVUUNGDEIR; [M+H]+; 4-{5H,6H,7H-pyrrolo[2,1-c][1,2,4]triazol-3-yl}piperidine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -204.597; BCLUIVUVYKKIPK; [M+C2H3N+H]+; N-[2-(1H-imidazol-5-yl)ethyl]cyclopropanamine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -216.693; GKZWSNRSZYTGJU; [M+C2H3N+H]+; 2,4-dimethylbenzene-1,3,5-triamine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -219.336; TVARKMCEMIFLIP; [M+C2H3N+H]+; N-4-Aminofenylethylendiamin
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -232.088; NNOWKRZSPSNRCP; [M+H]+; (2-(N-Methylanilino)ethyl)guanidine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -241.923; NTAYHZGUFNPVLG; [M+H]+; 1,5,6,7-tetrahydrospiro[imidazo[4,5-c]pyridine-4,4''-piperidine]
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -246.484; AVTLBBWTUPQRAY; [M+H]+; VAZO&trade; 67
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -252.532; AEPYIICGYIUTCV; [M+C2H3N+H]+; 1,2,4-benzenetriamine,n4,n4-dimethyl-
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -313.011; QUWILARGNKEHLL; [M+H]+; (3-Phenylpropyl)aminoguanidine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -336.647; GXUANFDVJSTLSO; [M+H]+; N,N-Dimethyl-2-(2-methylphenyl)hydrazinecarboximidamide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -371.944; XESVQSUDOVRMKL; [M+H]+; 2-(N-Cyanimino)-3-dimethylaminoethylenehexahydroazepine
COMMENT: PROPOSED_COMPOUND SIRIUS5_Confidence:biodatabase 0.485; QLTXFTSBONWMPM; [M+H]+; 4,6-dimethyl-2-piperazinylpyrimidine
COMMENT: PROPOSED_COMPOUND SIRIUS5_Confidence:biodatabase 0.308; CKEIQUPFORBNCK; [M+C2H3N+H]+; Di(3-cianopropil)ammina
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -65.690; QLTXFTSBONWMPM; [M+H]+; 1-(4,6-Dimethyl-2-pyrimidyl)piperazine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -67.772; NARMKNJWXHFJFF; [M+H]+; 2,4-Dimethyl-6-(piperazin-1-yl)pyrimidine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -78.472; CKEIQUPFORBNCK; [M+C2H3N+H]+; Butyronitrile, 4,4'-iminodi-
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -94.001; FCKYIGWJVZIPLK; [M+C2H3N+H]+; 4-(1H-pyrazol-5-yl)piperidine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -97.747; PJGDNWHBPXCOKM; [M+C2H3N+H]+; 1,3-Dimethyl-5,6,7,8-tetrahydroimidazo[1,5-a]pyrazine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -108.662; YJNKIVCXVAKYRD; [M+C2H3N+H]+; 4-(1H-imidazol-2-yl)piperidine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -112.672; WUWAAVDRLMQLJM; [M+C2H3N+H]+; 5H,6H,7H,8H-imidazo[1,2-a]pyridin-2-ylmethanamine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -112.916; JEZRDACHQQVYIB; [M+C2H3N+H]+; 5H,6H,7H,8H-imidazo[1,2-a]pyridin-3-ylmethanamine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -119.473; KWEVSQUHBXYCKQ; [M+C2H3N+H]+; 1-methyl-1H,4H,5H,6H,7H,8H-pyrazolo[4,3-c]azepine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -123.255; CFZKRYFTIHMWBI; [M+C2H3N+H]+; 3-(1H-imidazol-2-yl)piperidine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -123.907; DZMZZFAVAYXTJD; [M+C2H3N+H]+; 3-(1H-pyrazol-5-yl)piperidine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -124.006; PXQUZLDSPUWIHH; [M+C2H3N+H]+; 4-(1H-pyrazol-4-yl)piperidine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -130.778; GRUYWRRKXBOGDW; [M+H]+; 3-cyclopentyl-5H,6H,7H,8H-[1,2,4]triazolo[4,3-a]pyrazine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -132.796; SBHJKIRVTPGZOV; [M+H]+; 6-(4-Methylpiperazin-1-yl)pyridin-2-amine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -134.482; NZTCEWZBMOTKCJ; [M+H]+; 6-(4-Methylpiperazin-4-ium-1-yl)pyridin-3-amine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -135.767; IFHQJBQZOLOOHW; [M+H]+; 2-(4-Methylpiperazin-1-yl)pyridin-3-amine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -138.420; LHALOVXPEFNOGI; [M+H]+; 1-Methyl-4-(pyrazin-2-yl)-1,4-diazepane
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -142.522; OIFIPRUEJLZKTO; [M+H]+; 2-[5-(cyanomethyl)-1,5-diazocan-1-yl]acetonitrile
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -146.100; KFGHIVUUNGDEIR; [M+H]+; 4-{5H,6H,7H-pyrrolo[2,1-c][1,2,4]triazol-3-yl}piperidine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -146.952; WZODRKCBBZZALX; [M+H]+; 2-(4-Methylpiperazin-1-yl)pyridin-4-amine
COMMENT: PROPOSED_COMPOUND SIRIUS6_Confidence:biodatabase 0.280; CKEIQUPFORBNCK; [M+C2H3N+H]+; Butyronitrile, 4,4'-iminodi-
COMMENT: PROPOSED_COMPOUND SIRIUS6_Confidence:biodatabase 0.222; QLTXFTSBONWMPM; [M+H]+; 1-(4,6-Dimethyl-2-pyrimidyl)piperazine
COMMENT: CONFIDENCE Level 5: Exact mass of interest 193.144749; Observed in MS1; Charge state +1;
CH$NAME: Uncharacterized
CH$COMPOUND_CLASS: Uncharacterized
CH$FORMULA: C39H42O2
CH$EXACT_MASS: 542.318480
CH$SMILES: CCCC#Cc1cc(C#CCCC)cc(C#Cc2cc(C#CC(C)(C)C)c(cc2C#CC(C)(C)C)C2OCCO2)c1
CH$IUPAC: InChI=1S/C39H42O2/c1-9-11-13-15-30-25-31(16-14-12-10-2)27-32(26-30)17-18-33-28-35(20-22-39(6,7)8)36(37-40-23-24-41-37)29-34(33)19-21-38(3,4)5/h25-29,37H,9-12,23-24H2,1-8H3
CH$LINK: PUBCHEM CID:11353257
SP$SCIENTIFIC_NAME: Homo sapiens
SP$LINK: NCBI-TAXONOMY 9606 
SP$SAMPLE: Serum
AC$INSTRUMENT: Nexera X2 UHPLC system, Shimadzu - Q Exactive Orbitrap, Thermo Scientific
AC$INSTRUMENT_TYPE: LC-ESI-QFT
AC$MASS_SPECTROMETRY: MS_TYPE MS2
AC$MASS_SPECTROMETRY: ION_MODE POSITIVE
AC$MASS_SPECTROMETRY: COLLISION_ENERGY 20 V
AC$MASS_SPECTROMETRY: COLLISION_GAS N2
AC$MASS_SPECTROMETRY: FRAGMENTATION_MODE CID
AC$MASS_SPECTROMETRY: ION_SPRAY_VOLTAGE 4.0 kV
AC$MASS_SPECTROMETRY: IONIZATION ESI
AC$MASS_SPECTROMETRY: MASS_ACCURACY MS1(ppm) 0.75; MS2(ppm) 4.00
AC$CHROMATOGRAPHY: COLUMN_NAME GL-HilicAex 2.1 x 150 mm, 5 mm (Resonac)
AC$CHROMATOGRAPHY: FLOW_GRADIENT B conc(%). 0 min: 95, 0.5 min: 95, 15.5 min: 40, 16.5 min: 0, 26.5 min: 0, 27.5 min: 95, 35 min: 95.
AC$CHROMATOGRAPHY: FLOW_RATE 0.4 mL/min
AC$CHROMATOGRAPHY: RETENTION_TIME 5.733
MS$FOCUSED_ION: PRECURSOR_M/Z 193.144749
MS$DATA_PROCESSING: RECALIBRATE Data dependent recalibration using whole DDA dataset
PK$SPLASH: splash10-0006-0900000000-cac94b45f42d2a76e150
PK$ANNOTATION: m/z int annotation m/z_nocal m/z_std(ppm) int_std cor n
  59.0491021 47.3566 ? 59.049740 1.4564 15.91 -0.0605 242
  81.0698239 20.9797 ? 81.070350 2.1586 6.93 0.1526 181
  95.0854403 30.7028 ? 95.085800 1.6617 11.22 -0.0306 236
  97.0759450 28.0457 ? 97.076290 1.7924 8.11 0.4477 229
  109.1011133 22.1613 ? 109.101350 2.2365 7.54 0.1076 183
  119.0854685 22.7973 ? 119.085590 2.1917 8.77 -0.0627 181
  123.0916012 33.3189 ? 123.091670 1.7223 7.94 0.7688 233
  133.1011790 27.2629 ? 133.101100 2.1863 9.95 -0.0934 220
  149.1324616 21.9007 ? 149.132360 2.5414 7.63 0.0763 180
  150.1025422 29.9507 ? 150.102440 2.3051 8.82 0.7675 228
  175.1481883 124.9632 ? 175.148070 1.1590 38.34 0.0226 241
  176.1182789 51.7272 ? 176.118160 1.8113 19.13 -0.0108 242
  193.1089346 134.1890 ? 193.108805 1.9678 79.94 -0.3622 242
  193.1445496 999.0000 ? 193.144420 1.2322 0.00 1.0000 242
  193.1592796 181.4863 ? 193.159150 1.0665 60.24 -0.0391 241
PK$NUM_PEAK: 15
PK$PEAK: m/z int. rel.int.
  59.049102 47.36 47
  81.069824 20.98 20
  95.085440 30.70 30
  97.075945 28.05 28
  109.101113 22.16 22
  119.085469 22.80 22
  123.091601 33.32 33
  133.101179 27.26 27
  149.132462 21.90 21
  150.102542 29.95 29
  175.148188 124.96 124
  176.118279 51.73 51
  193.108935 134.19 134
  193.144550 999.00 999
  193.159280 181.49 181
//
